Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association - PubMed (original) (raw)
Review
Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association
Majid Fotuhi et al. Nat Clin Pract Neurol. 2009 Mar.
Abstract
Long-chain omega-3 fatty acids could have neuroprotective properties against dementia, which is becoming a major global public health issue. We conducted a systematic review of the literature to establish the association between eating fish (a source of long-chain omega-3 fatty acids) or taking long-chain omega-3 fatty acid supplements and the risk of cognitive decline or Alzheimer disease (AD). We identified eleven observational studies and four clinical trials. All three observational studies that used cognitive decline as an outcome reported significant benefits, whereas only four of eight observational studies that used incidence of AD or dementia as an outcome reported positive findings. None of four small clinical trials provided convincing evidence for the use of this approach in the prevention or treatment of any form of dementia. In summary, the existing data favor a role for long-chain omega-3 fatty acids in slowing cognitive decline in elderly individuals without dementia, but not for the prevention or treatment of dementia (including AD). This apparent dichotomy might reflect differences in study designs with regard to participants, dosages, the ratio of long-chain omega-3 to omega-6 fatty acids, or the choice of outcome measurements. Large clinical trials of extended duration should help to provide definitive answers.
Similar articles
- Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.
Zhang Y, Chen J, Qiu J, Li Y, Wang J, Jiao J. Zhang Y, et al. Am J Clin Nutr. 2016 Feb;103(2):330-40. doi: 10.3945/ajcn.115.124081. Epub 2015 Dec 30. Am J Clin Nutr. 2016. PMID: 26718417 - Diet and Alzheimer's disease risk factors or prevention: the current evidence.
Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A. Solfrizzi V, et al. Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56. Expert Rev Neurother. 2011. PMID: 21539488 Review. - Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.
Canhada S, Castro K, Perry IS, Luft VC. Canhada S, et al. Nutr Neurosci. 2018 Oct;21(8):529-538. doi: 10.1080/1028415X.2017.1321813. Epub 2017 May 3. Nutr Neurosci. 2018. PMID: 28466678 - Omega 3 fatty acids and cognitive health in older people.
Dangour AD, Andreeva VA, Sydenham E, Uauy R. Dangour AD, et al. Br J Nutr. 2012 Jun;107 Suppl 2:S152-8. doi: 10.1017/S0007114512001547. Br J Nutr. 2012. PMID: 22591889 Review. - A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW, Jensen MT, Salem N Jr, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H. Arendash GW, et al. Neuroscience. 2007 Oct 26;149(2):286-302. doi: 10.1016/j.neuroscience.2007.08.018. Epub 2007 Aug 14. Neuroscience. 2007. PMID: 17904756
Cited by
- Gut Microbiota: A Modulator of Brain Plasticity and Cognitive Function in Ageing.
Leung K, Thuret S. Leung K, et al. Healthcare (Basel). 2015 Sep 29;3(4):898-916. doi: 10.3390/healthcare3040898. Healthcare (Basel). 2015. PMID: 27417803 Free PMC article. Review. - Moving beyond "good fat, bad fat": the complex roles of dietary lipids in cellular function and health: session abstracts.
Abumrad NA, Piomelli D, Yurko-Mauro K, Merrill A, Clandinin MT, Serhan CN. Abumrad NA, et al. Adv Nutr. 2012 Jan;3(1):60-8. doi: 10.3945/an.111.000802. Epub 2012 Jan 5. Adv Nutr. 2012. PMID: 22332103 Free PMC article. - Promising strategies for the prevention of dementia.
Middleton LE, Yaffe K. Middleton LE, et al. Arch Neurol. 2009 Oct;66(10):1210-5. doi: 10.1001/archneurol.2009.201. Arch Neurol. 2009. PMID: 19822776 Free PMC article. Review. - Diet quality is associated with better cognitive test performance among aging men and women.
Wengreen HJ, Neilson C, Munger R, Corcoran C. Wengreen HJ, et al. J Nutr. 2009 Oct;139(10):1944-9. doi: 10.3945/jn.109.106427. Epub 2009 Aug 12. J Nutr. 2009. PMID: 19675102 Free PMC article. - Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.
Bazan NG, Molina MF, Gordon WC. Bazan NG, et al. Annu Rev Nutr. 2011 Aug 21;31:321-51. doi: 10.1146/annurev.nutr.012809.104635. Annu Rev Nutr. 2011. PMID: 21756134 Free PMC article.
References
- JAMA. 2004 Nov 10;292(18):2237-42 - PubMed
- Neurochem Res. 2002 Nov;27(11):1513-23 - PubMed
- Circulation. 2002 Nov 19;106(21):2747-57 - PubMed
- Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005379 - PubMed
- Brain Res. 2000 Apr 17;862(1-2):180-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical